Therapeutic Potential of Glucagon-Like Peptide-1 Receptor Agonists for Smoking Cessation.
Researchers reviewed evidence suggesting that GLP-1 drugs—medications already used for diabetes and weight management—may help people quit smoking by reducing nicotine cravings and preventing weight gain after quitting, offering a potentially more effective option than current smoking cessation treatments.
Relevance to India: None stated.